GlassScriptPhysician profile
Gerald Marsocci
NPI 1386649523
$2,499.09
in general payments reported to CMS, 2019-2025
17 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $69.70 · 2021: $182 · 2022: $300 · 2023: $221 · 2024: $530 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $960.81 | 2019-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Grafix Pl |
| Abbvie INC. | $587.42 | 2019 | |
| Misonix INC | $347.18 | 2019-2021 | |
| Kerecis Limited | $139.23 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $129.68 | 2020-2023 | Activ.A.C. |
| Lifenet Health | $69.83 | 2024 | Theragenesis Wound Matrix |
| Reapplix INC. | $46.88 | 2025 | 3c Patch Kit - Box |
| Integra Lifesciences Corporation | $36.92 | 2021-2024 | Tcc-Ez |
| Hydrofera LLC | $27.30 | 2024 | Hydrofera Blue |
| Molnlycke Health Care US, LLC | $26.91 | 2023 | Mepilex Border Flex, Mepilex Border Sacrum, Mepilex Ag |
| Davol INC. | $24.12 | 2021 | |
| Cashflow Solutions, LLC | $19.23 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Organogenesis INC. | $19.05 | 2020 | |
| Solventum Corporation | $18.25 | 2025 | Activ.A.C. |
| Tactile Systems Technology INC | $15.69 | 2025 | Nimbl, Flexitouch Plus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $15.65 | 2024 | Miro3d |
| Mimedx Group, INC. | $14.94 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Marsocci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.